A detailed history of Federated Hermes, Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 5,208,300 shares of IDYA stock, worth $132 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
5,208,300
Previous 4,855,790 7.26%
Holding current value
$132 Million
Previous $170 Million 3.22%
% of portfolio
0.38%
Previous 0.41%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.37 - $43.05 $10.7 Million - $15.2 Million
352,510 Added 7.26%
5,208,300 $165 Million
Q2 2024

Aug 08, 2024

SELL
$34.37 - $43.46 $9,898 - $12,516
-288 Reduced 0.01%
4,855,790 $170 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $33.3 Million - $45.8 Million
972,303 Added 25.03%
4,856,078 $213 Million
Q4 2023

Jan 31, 2024

BUY
$24.59 - $35.83 $12.3 Million - $17.9 Million
500,046 Added 14.78%
3,883,775 $138 Million
Q3 2023

Nov 13, 2023

SELL
$21.07 - $29.77 $125,766 - $177,697
-5,969 Reduced 0.18%
3,383,729 $91.3 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $7 Million - $13.4 Million
525,091 Added 18.33%
3,389,698 $79.7 Million
Q1 2023

May 08, 2023

BUY
$13.49 - $18.72 $1,443 - $2,003
107 Added 0.0%
2,864,607 $39.3 Million
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $34,858 - $43,771
2,409 Added 0.08%
2,864,500 $52 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $6.47 Million - $11.1 Million
700,000 Added 32.38%
2,862,091 $42.7 Million
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $721,096 - $1.21 Million
-87,089 Reduced 3.87%
2,162,091 $29.8 Million
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $459,520 - $987,270
-41,102 Reduced 1.79%
2,249,180 $25.2 Million
Q4 2021

Feb 14, 2022

SELL
$20.95 - $26.88 $312,029 - $400,350
-14,894 Reduced 0.65%
2,290,282 $54.1 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $11.5 Million - $18.1 Million
668,237 Added 40.82%
2,305,176 $58.8 Million
Q2 2021

Aug 16, 2021

BUY
$17.76 - $24.83 $2.32 Million - $3.25 Million
130,727 Added 8.68%
1,636,939 $34.4 Million
Q1 2021

May 13, 2021

BUY
$13.48 - $23.77 $5.5 Million - $9.69 Million
407,864 Added 37.13%
1,506,212 $35.4 Million
Q4 2020

Feb 12, 2021

BUY
$12.17 - $17.52 $13.4 Million - $19.2 Million
1,097,266 Added 101410.91%
1,098,348 $15.4 Million
Q3 2020

Nov 12, 2020

BUY
$11.22 - $14.46 $12,140 - $15,645
1,082 New
1,082 $14,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.22B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.